ARTICLE | Company News
CMS to discuss Provenge use
September 2, 2010 12:39 AM UTC
CMS's Medicare Evidence Development & Coverage Advisory Committee will meet on Nov. 17 to discuss the "labeled and unlabeled" use of autologous cellular immunotherapy to treat prostate cancer. In June...